Barrett’s Esophagus Prognostic Test Highlighted at Scientific Meeting
Previse presented clinical utility data for their epigenetic test Esopredict, which aids in optimizing care for Barrett’s esophagus patients.
Read MorePosted by Chris Wolski | Oct 29, 2024 | Unknown Origin & Other Cancer Types |
Previse presented clinical utility data for their epigenetic test Esopredict, which aids in optimizing care for Barrett’s esophagus patients.
Read MorePosted by Andy Lundin | Oct 25, 2024 | Cardiovascular, Prenatal Testing |
The biomarker could enable prenatal detection of single ventricle heart disease through a maternal blood test for earlier diagnosis.
Read MorePosted by Andy Lundin | Oct 24, 2024 | Molecular Diagnostics |
Early results from a new study demonstrate that genomic sequencing identifies significantly more treatable health conditions in newborns.
Read MorePosted by Andy Lundin | Oct 23, 2024 | Molecular Diagnostics, Urinalysis & Toxicology |
Researchers are exploring urine analysis as a tool for early detection of diseases by studying RNA and other substances in urine.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Lung Cancer, Molecular Diagnostics |
NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.
Read More